Human C-Reactive Protein (CRP)

Human C-reactive protein (CRP) is one of the socalled acute phase proteins. CRP is produced in liver and its concentration in blood increases rapidly as a response to inflammation. It is routinely used as a non-specific marker of inflammation. CRP is a 224-residue protein with a monomer molecular mass of approximately 25 kDa and pI 6.4 (1-4). It belongs to pentraxins, an evolutionally conserved family of proteins characterized by calcium dependent ligand binding and radial symmetry of five monomers forming a ring around central pore (5). The total mass of the CRP pentamer is approximately 120 kDa. The precise function of CRP in vivo is still not yet completely clear, but it has been shown that CRP increases by the secretion of interleukin-6 produced by for example macrophages and T cells (6). CRP has been shown to participate in inflammatory as well as innate immunity processes. The level of CRP in the blood of healthy people is usually low but in infections caused by bacteria the concentration of CRP can quite easily increase tenfold. In contrast, infections of viral origin usually result in just a moderate increase in the level of CRP. Important Clinical and Research Area CLINICAL UTILITY ü Prediction of future cardiovascular risk ü Inflammation bioactivities of CRP are determined by its ability to bind to a variety of ligands, such as damaged cell membranes, apoptotic cells and fibronectin, with the highest affinity to phosphocholine residues. When CRP is ligand-bound, it can be recognized by the complement component C1q, which leads to activation of the classical complement pathway. On the other hand, via interaction with the complement factor H, CRP regulates the alternative complement pathway (7).


Search C-Reactive Protein references from PubMed.
See all CRP References.

Related products:

See other cardiac markers and blood coagulation products

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!